Introduction
============

Natural killer (NK) cells are innate immune cells whose function is critical in the first-line of defense against different types of pathogens, including viruses, bacteria and fungi ([@b1-etm-0-0-4189],[@b2-etm-0-0-4189]). Furthermore, NK cells are associated with immune surveillance against tumors, hinder the dissemination of metastatic tumors, and perform essential functions in regulating autoimmune diseases ([@b3-etm-0-0-4189],[@b4-etm-0-0-4189]). Unlike T and Blymphocytes, NK cells are constitutively able to kill target cells without prior sensitization; additionally, NK cells exhibit a variety of activating and inhibitory receptors that allow for activation and inhibition signaling, which may determine the cytotoxicity of NK cells ([@b5-etm-0-0-4189]).

NK cells are present in all lymphoid organs and mature NK cells may be detected in the liver, peripheral blood and spleen ([@b6-etm-0-0-4189]). NK1.1 has been used to distinguish NK cells in specific murine strains, including C57Bl/6 ([@b7-etm-0-0-4189]). Cluster of differentiation (CD)-49b may associate with DX5 antibody and is also a well-known NK cell marker in different mouse strains, uch as BALB/c ([@b8-etm-0-0-4189]). The isolation of purified and newly separated NK cells poses a challenge as NK cells only constitute \~2.5% of mouse splenocytes ([@b9-etm-0-0-4189]).

Previous studies have determined multiple approaches for purifying splenic NK, such as the methods of NK cell isolation proposed by Ravnik *et al* ([@b10-etm-0-0-4189]) and Patel and Linna ([@b11-etm-0-0-4189]), which were based on the differentiation of cells via density gradient centrifugation with continuous or discontinuous percoll gradients. However, flow cytometry has indicated that \<40% of density-separated cells were NK1.1^+^CD3ε^−^, particularly from spleens of C57BL/6 mice ([@b10-etm-0-0-4189],[@b11-etm-0-0-4189]). Advancement in technology has allowed for the development of the novel method, magnetic-activated cell sorting (MACS). MACS sorting is a popular method applied in areas concerning immunology, cancer research, neuroscience, and stem cell research. Through this approach, cells are positively or negatively separated, depending on specific antigens present ([@b12-etm-0-0-4189]). For NK cell sorting, positive selection may be gaged by selecting antibodies against NKp46 or CD49b (DX5) and negative selection may be achieved for naïve NK cell purification using commercially available kits.

Different conclusions and several problems have been identified in the purification of murine NK cells as the result of using different commercial kits ([@b13-etm-0-0-4189]). For that reason, an extensive comparative study of four different NK cells isolation kits based on MACS separation in C57Bl/6 mice was performed in the present study. The present study recognized that NK cells are short-lived and IL-2-dependent *in vitro*. Thus, the concentration of IL-2 was an important factor to consider when evaluating the effects of various drugs on NK cells. Consequently, the approach of the present study required freshly isolated NK cells and evaluated the purity and viability of NK cells in the absence or presence of different concentration of IL-2 for 24, 48 or 72 h.

Materials and methods
=====================

### Animals

A total of 30 female 6-8-week-old C57BL/6 mice weighing 18--20 g were obtained from Harlan Slac Laboratory Animals Co., Ltd. (Shanghai, China). Mice were maintained at China Medical University in a pathogen-free animal house. Mice were housed in a temperature (21±1°C), humidity (55±10%), and 12-h light/dark cycle controlled room. Food and water were available *ad libitum*. All experiments with animals were performed in accordance with the Guide for the Care and Use of Laboratory Animals as approved by the China National Institutes of Health.

### Cell culture

Freshly isolated NK cells using the Stemcell Mouse NK Cell Isolation kit (catalogue no. 19855; STEMCELL Technologies, Inc., Cambridge, UK) were cultured in Roswell Park Memorial Institute-1640 medium (Biological Industries, Kibbutz Beit-Haemek, Israel) supplemented with 10% fetal bovine serum (FBS; Biological Industries), 2 mM L-glutamine (Lonza, Shanghai, China), 50 µM β-mercapto ethanol (Sigma-Aldrich; Merck Millipore, Darmstadt, Germany) and antibiotics (100 U/ml penicillin, 100 µg/ml streptomycin and 100 µg/ml kanamycin) (HyClone; GE Healthcare Life Sciences, Logan, UT, USA) at a density of 5×10^5^ cells/ml in 96-well flat plates. NK cells were cultured for 24, 48 or 72 h in the absence or presence of IL-2 (PeproTech, Inc., Rocky Hill, NJ, USA). At the designated time points, NK cells were assessed for viability and surface phenotype using flow cytometry (FCM). Cells were maintained in a humidified atmosphere containing 5% CO~2~ and 95% air at 37°C.

### Sample preparation for magnetic activated cell sorting (MACS)

Mice were anesthetized by intraperitoneal injection of Inactin (thiobutabarbital, 100 mg/kg; Sigma-Aldrich; Merck Millipore) and sacrificed by cervical dislocation, and spleens were removed by mechanical dissociation and placed on a petri dish containing pre-cooled phosphate-buffered saline (PBS) supplemented with 2% FBS as described previously ([@b12-etm-0-0-4189]). Spleens were mashed using a moisturized cell strainer (70-µm nylon mesh) using a plunger and a cell strainer positioned above a 50-ml conical tube was used to transfer the single cell suspension through the strainer into the tube. The petri dish and the strainer were rinsed with pre-cooled PBS supplemented with 2% FBS. Erythrocytes were lysed with ammonium chloride potassium lysing buffer. Subsequently, murine splenocytes were transferred through another 70-µm cell strainer into a new 50-ml conical tube. Cell numbers were counted by trypan blue exclusion. Following the different cell isolation procedures, NK cell fractions were harvested, visualized under a light microscope and the number of cells counted on a hemocytometer using trypan blue (the percentage of viable cells=total cells-blue cells/total cells). Subsequently, FCM analysis was performed (as described in Flow cytometry) to determine the percentage of NK cells (the percentage of NK cells=all cells at lymphocyte locations/total cells) vs. contaminating lymphocytes (the percentage of contaminating lymphocytes=all cells at granulocyte locations/total cells) using BD FACS DIVA version 6.0 software (BD Biosciences, San Jose, CA, USA).

### Miltenyi NK Cell Isolation Kit II

The NK Cell Isolation kit II was used according to the manufacturer\'s instructions (130-096-892) by using an LS column on the Midi MACS separator (both Miltenyi Biotec GmbH, Bergisch Gladbach, Germany). Splenocyte suspensions (1×10^8^ cells/ml) were centrifuged at 300 × g for 10 min at 4°C and resuspended in 400 µl isolation buffer (containing PBS, pH 7.2, 0.5% bovine serum albumin and 2 mM ethylenediaminetetraacetic acid). Subsequently, 100 µl NK cell biotin-antibody mixture was added, and the mixture was incubated for 5 min in the refrigerator (2--8°C). Following washing with isolation buffer, splenocytes were resuspended in 800 µl isolation buffer. Subsequently, 200 µl anti-biotin microbeads were added and cells were incubated for an additional 10 min in the refrigerator (2--8°C). During the incubation period, the LS column was prepared by rinsing with 3 ml of isolation buffer. Cell suspensions were loaded onto the column and the flow-through containing unlabeled cells was collected, representing the enriched NK cells. To obtain more NK cells, the column was subsequently washed with 3 ml isolation buffer again and the flow-through cells were collected.

### Miltenyi CD49b (DX5) positive selection kit

CD49b (DX5) microbeads were used according to the manufacturer\'s instructions (130-052-501) using an MS Column on the MiniMACS separator (Miltenyi Biotec, GmbH). Splenocyte suspensions at a density of 1×10^8^ cell/ml were centrifuged at 300 × g for 10 min at 4°C and resuspended in 900 µl isolation buffer. A total of 100 µl CD49b (DX5) microbeads were added and cells were incubated for 15 min at 4--8°C. Following washing with isolation buffer, splenocytes were resuspended in 500 µl isolation buffer and the MS column was prepared by rinsing with 500 µl isolation buffer. The cell suspension was applied onto the column and cells were washed with isolation buffer three times. Subsequently, the column was removed from the separator and placed on a 15 ml conical tube. A total of 1 ml buffer was pipetted onto the column and the fraction was immediately flushed out using magnetically labeled cells by firmly applying the plunger supplied with the column, providing the purified CD49b^+^ cells.

### Stemcell CD49b Positive Selection kit

The Mouse CD49b Positive Selection kit was performed according to the manufacturer\'s instructions (18755; Stemcell Technologies UK Ltd., Cambridge, UK) using Falcon 5-ml polystyrene round-bottom tubes (352058; BD Biosciences) on a purple EasySep magnet (18000; Stemcell Technologies UK Ltd.). Splenocyte suspensions (1×10^8^ cells/ml) were centrifuged at 300 × g for 10 min at 4°C and resuspended in 1 ml sorting buffer (PBS and 2% FBS with 1 mM ethylenediaminetetraacetic acid) in a 5 ml (12×75 mm) polystyrene tube. Subsequently, 50 µl EasySep mouse CD49b phycoerythrin (PE) labeling reagent was added, and the suspension was incubated at room temperature (15--25°C) for 15 min. A total of 100 µl EasySep PE selection cocktail was added and the cells were incubated at room temperature for 15 min. Subsequently, 50 µl nanoparticles were added and the cells were incubated at room temperature for 10 min. Finally, the cell suspensions were made to a total volume of 2.5 ml by adding the recommended medium, and were placed into the magnet for 5 min. The supernatant fraction was poured off three times following 5 min separations in the magnet. Magnetically-labeled cells (positively selected cells) remained inside the tube; the tube was removed from the magnet and cells were resuspended in 1 ml desired medium.

### Stemcell Mouse NK Cell Isolation kit

The Mouse NK Cell Isolation kit was used according to the manufacturer\'s instructions (19855; Stemcell Technologies UK Ltd.) using Falcon 5-ml polystyrene round-bottom tubes on the EasySep magnet. Splenocyte suspensions at a density of 1×10^8^ cells/ml were centrifuged at 300 × g for 10 min at 4°C and resuspended in 1 ml of recommended medium in a 5-ml polystyrene tube. A total of 50 µl EasySep mouse NK cell isolation cocktail was added, and cells were incubated at room temperature (15--25°C) for 10 min. Subsequently, 100 µl EasySep Streptavidin RapidSpheres 50002 was added, and cells were incubated at room temperature (15--25°C) for 5 min. Cell suspensions were brought up to a total volume of 2.5 ml by adding the recommended medium, and were placed into the magnet for 5 min at room temperature (15--25°C). The EasySep magnet was removed and the desired fraction was poured off into a 15-ml tube three times following 5 min separations in the magnet. The isolated cells in the 15-ml tube were naïve NK cells.

### Modified NK cell isolation

To obtain high purity NK cells, the Miltenyi CD3ε MicroBead kit (130-094-973) was used in combination with a Miltenyi CD49b (DX5) positive selection kit. Splenocytes were labeled with CD3ε-biotin and the cells were magnetically labeled with anti-biotin micro beads. Cell suspensions were loaded onto the MACS column, which was placed in the magnetic field of a MACS separator. Magnetically labeled CD3ε^+^ cells were retained within the column, while the unlabeled cells ran through. This cell fraction was depleted of CD3ε^+^ cells. Subsequently, the CD49b (DX5) micro beads were used according to the manufacturer\'s instructions to isolate NK cells from the cell fraction depleted of CD3ε^+^ cells.

### Flow cytometry

Anti-mouse antibodies used for flow cytometry were as follows: PE-conjugated anti-NK1.1 (PK136; catalogue no. 108707; 1:100), allophycocyanin-conjugated anti-NK1.1 (PK136; catalogue no. 108709; 1:100), Fluorescein isothiocyanate-conjugated anti-CD3ε (145-2C11; catalogue no. 100305; 1:100), PE-conjugated anti-F4/80 (BM8; catalogue no. 123109; 1:100), PE-conjugated anti-CD8a (53-6.7; catalogue no. 100707; 1:100), peridininchlorophyll protein complex-CY5.5-conjugated anti-CD4 (GK1.5; catalogue no. 100434; 1:100) (BioLegend, Inc., San Diego, CA, USA). Cell viability was confirmed by staining the cells with 7-aminoactinomycin D (420404; 1:100; BioLegend, Inc.). NK cell purity was evaluated using flow cytometry as described previously ([@b12-etm-0-0-4189]). Briefly, freshly isolated NK cells or cultured NK cells were collected and washed in PBS twice. Then cells were resuspended in 100 µl staining buffer (421002; BioLegend, Inc.) and incubated on ice for 15 min with combination of PE-conjugated anti-NK1.1 or APC-conjugated anti-NK1.1 and FITC-conjugated anti-CD3ε antibodies. After extensive washing with PBS, cells were resuspended in 500 µl PBS and 5 µl 7-AAD was added into the suspension for 10 min. The stained cells were then analyzed by FCM. A minimum of 10,000 events was acquired using a FACS Canto II flow cytometer and analyzed with BD FACS DIVA version 6.0 software (BD Biosciences).

### Statistical analysis

Statistical analysis was performed using SPSS 16.0 statistical software package (SPSS, Inc., Chicago, IL, USA). Values were expressed as the mean ± standard deviation from at least three independent experiments. Statistical significance of differences was determined by a one-way analysis of variance analysis using the Bonferroni t-test. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Purity of NK cells purified with Miltenyi NK Cell Isolation kit II

The proportion of NK cells was first detected in female C57Bl/6 mice of identical age. For this purpose, FCM analysis of NK cells, defined as NK1.1^+^CD3ε^−^, was performed in viable splenocytes. Results indicated that in C57Bl/6 mice, the spleen contained 2.63±0.31% NK cells ([Fig. 1](#f1-etm-0-0-4189){ref-type="fig"}). To confirm cell purity and the success of the isolation procedure of the Miltenyi NK Cell Isolation kit II, isolated cells were phenotyped by FCM for the expression of NK1.1 and CD3ε. NK cell purity in the gated population was 81.47±3.98% ([Fig. 2A](#f2-etm-0-0-4189){ref-type="fig"}); however, the percentage of the gated NK cells population based on forward and side scatter characteristics was 34.37±5.41% ([Fig. 2A](#f2-etm-0-0-4189){ref-type="fig"}). There was a large population (33.83±5.58%; [Fig. 2A](#f2-etm-0-0-4189){ref-type="fig"}) at the position of granulocytes; however, the percentage was only 1.83±0.15% in the splenocytes ([Fig. 1](#f1-etm-0-0-4189){ref-type="fig"}). To identify the prosperity of this population, cells were stained with F4/80 antibody. The findings revealed that almost all of the population was F4/80 positive ([Fig. 2](#f2-etm-0-0-4189){ref-type="fig"}). Isolated cells were cultured with 500 U/ml IL-2 for 24 h to deplete this population. Notably, following the subsequent depletion step, almost all cells underwent cell death and the percentages of gated NK cells and NK cell purity were increased ([Fig. 2B](#f2-etm-0-0-4189){ref-type="fig"}).

### Purity obtained with Miltenyi CD49b (DX5) positive selection kit

Isolated cells from the Miltenyi CD49b (DX5) positive selection kit were phenotyped by FCM for the expression of NK1.1 and CD3ε. Results indicated that the NK cell purity from this kit was \~51.50±4.52% ([Fig. 1](#f1-etm-0-0-4189){ref-type="fig"}). However, this kit presented with certain issues. The percentage of the granulocyte population (9.07±1.19%) was significantly increased when compared with that in the normal splenocytes (1.83±0.15%; P=0.005). Furthermore, the percentage of natural killer T (NKT) cells, defined as the NK1.1^+^CD3ε^+^ (10.8±1.49%) population, was increased in the isolated viable lymphocyte population when compared with the splenocytes (1.13±0.25%), which were also contaminated with numerous CD3ε^+^ NK1.1^−^ cells (32.97±4.17%; [Fig. 1](#f1-etm-0-0-4189){ref-type="fig"}).

### Purity of Stemcell CD49b Positive Selection kit

Since the positively selected cells of the Stemcell CD49b Positive Selection kit were already PE-labeled, the purity was assessed directly by FCM. Anticipated results were achieved using the recommended marker in this kit and the CD49b^+^ (DX5) cell content of selected cells was 92.90±2.36% ([Fig. 3](#f3-etm-0-0-4189){ref-type="fig"}). To confirm NK cell purity, cells were phenotyped by FCM for the expression of NK1.1 and CD3ε, following purification. Surprisingly, the NK cell purity was only 64.93±2.62% and the gated cell population was also slightly contaminated with NKT cells (6.60±1.21%). Furthermore, purified cells were analyzed using another NK cell marker, CD49b^+^CD3ε^−^. The percentage of CD49b^+^CD3ε^−^ cell population was 79.40±2.95% and the CD49b^+^ cells included a large population of CD3ε^+^ cells (13.87±2.56%; [Fig. 3](#f3-etm-0-0-4189){ref-type="fig"}).

### Purity of Stemcell Mouse NK Cell Isolation kit

NK cell purity as determined by the Stemcell Mouse NK Cell Isolation kit was 81.97±3.40% in the viable lymphocyte population, following purification. No contaminated cells were identified at the position of granulocytes and no NKT cell contamination was observed ([Fig. 4](#f4-etm-0-0-4189){ref-type="fig"}).

### Purity of modified NK cell isolation

In the present study, the Miltenyi NK cell positive selection kit (DX5 positive selection kit) was observed to be contaminated with CD3ε^+^ cells. In order to deplete this population of cells, the Miltenyi CD3ε MicroBead kit was used in combination with the Miltenyi CD49b (DX5) positive selection kit. The efficiency of the Miltenyi CD3ε MicroBead kit was identified, and the results indicated a high purity of CD3^+^ cells were enriched in the positive portion without granulocyte contamination. Subsequently, the results of the Miltenyi CD3ε MicroBead kit were used combination with the Miltenyi CD49b (DX5) positive selection kit and showed that the NK cell purity was 73.23±2.83% and the NKT cell contamination was depleted. However, the contamination of granulocytes was not depleted (8.5±1.35%; [Fig. 5](#f5-etm-0-0-4189){ref-type="fig"}).

### Purity and viability of NK cells in presence of different concentrations of IL-2

Freshly isolated NK cells from murine stem cells were cultured using an NK cell isolation kit at a density of 5×10^5^ cells/ml in 96-well flat plates for 24, 48 or 72 h in the absence or presence of IL-2 (0, 100, 300 or 500 U/ml). The purity and viability of NK cells was assessed using FCM following culturing for 24, 48 or 72 h ([Fig. 6A-C](#f6-etm-0-0-4189){ref-type="fig"}) and the statistical analysis of the purity and viability were performed as presented in [Fig. 6E and F](#f6-etm-0-0-4189){ref-type="fig"}. Detailed results were presented in [Table I](#tI-etm-0-0-4189){ref-type="table"} and [Fig. 6](#f6-etm-0-0-4189){ref-type="fig"}. The results revealed that at higher IL-2 concentration, the NK cell purity and viability are significantly higher ([Fig. 6E and F](#f6-etm-0-0-4189){ref-type="fig"}; P\<0.05). The majority of NK cells under went cell death following 24 h in culture in absence of IL-2.

### Comparison of the purity and time required of different NK cell isolation kits

The purity and time required for NK cell isolation using different kits were compared as presented in [Fig. 7](#f7-etm-0-0-4189){ref-type="fig"}. Without consideration of the yield of purified NK cells, the NK cells purity and the time required of different kits are as follows: Miltenyi DX5 kit (51.50±4.52%, 50 min), Miltenyi NK Cell Isolation kit II (81.47±3.98%, 50 min), modified NK cell isolation (73.23±2.83%, 110 min), Stemcell CD49b Positive Selection kit (64.93±2.62%, 60 min), Stemcell Mouse NK Cell Isolation kit (81.97±3.40%, 30 min).

Discussion
==========

NK cells are innate lymphocytes that provide host protection against infectious diseases and cancer. *In vitro* studies of NK cells are necessary to obtain fundamental information on their function and the mechanisms of their interaction with other cells. Mouse models are considered useful tools in developing pre-clinical adoptive NK cell transfer immunotherapy against human tumors ([@b14-etm-0-0-4189]). A prerequisite for further detailed functional characterization of NK cells is how to optimize the purification method. In the present study, the purity of NK cells was identified to be varied among the different purification kits used, despite the same method being applied. More granulocytes were detected in the purified NK cells using the Miltenyi sorting kit, particularly while using the negative selection kit. The main drawback of DX5-positive selection using Stemcell and Miltenyi kits was that a high percentage of CD3ε^+^ cells were mixed into the isolated NK cells. Furthermore, a significant difference in NK cell purity was observed while the purification was performed using different surface markers. Therefore, the positive selection kit procedure was modified and a higher purity and yield of NK cells was obtained. Moreover, the purity of NK cells was compared with the viability with or without a range of concentrations of IL-2. These findings revealed that the higher IL-2 concentrations resulted in a higher purity of NK cells.

The purity and time required for NK cells isolation to occur in different kits was compared. Without consideration of the time required and the yield of purified NK cells, the NK cells purity in the gated viable mononuclear cell population of negative selection was higher than that of positive selection. As for the specific kits, NK cell purity of the Stemcell kit was higher when compared with the Miltenyi kit, particularly the positive selection kit. Compared with Stemcell kits, there was a severe issue with granulocyte contamination of the purified NK cells based on forward scatter and side scatter properties when using Miltenyi sorting kits, particularly with the negative selection kit, which affected the yield of NK cells. Following FCM identification, this contaminated population was identified as almost entirely F4/80 positive. Thus, it was speculated that this population was likely macrophages. In order to deplete this population from purified NK cells, the total isolated cells were cultured for 24 h. However, this population consisted of non-adherent cells and almost all cells underwent cell death following 24 h in culture. Thus, there are no macrophages in the contaminated population, thus they may be neutrophils, eosinophilic or basophile granulocytes because these cells are non-adherent and short-lived ([@b15-etm-0-0-4189]). The exact type of these contaminating cells requires further explanation. Additionally, the CD3ε-positive selection kit and DX5-positive selection kit were combined to achieve a high purity of NK cells. When the CD3ε-positive selection kit was initially used, granulocyte contamination was not identified in the positive fraction; however, after using the DX5-positive kit, the granulocytes contamination was detected again. These results confirmed the theory that contaminated cells were reserved due to CD49b expression, although the exact type of these contaminating cells (CD49b^+^F4/80^+^) requires further explanation. When NK cells were isolated using Miltenyi kits, the normal prepared spleen cells were not advantageous due to the enriched granulocytes observed following purification. We recommend that the spleen cells are pretreated first to deplete the granulocytes, which may be achieved by gradient centrifugation. Another disadvantage of NK cell isolation using DX5-positive selection according to both Stemcell and Miltenyi kits was that the isolates contained a high percentage of contaminating CD3ε^+^ cells, including NKT cells (NK1.1^+^CD3ε^+^) and some T cells (NK1.1^−^CD3ε^+^). The predominant reason for this problem is in the expression of CD49b. NKT cells and certain T cells may express CD49b ([@b16-etm-0-0-4189],[@b17-etm-0-0-4189]). Thus, using CD49b as sorting target may cause these cells to be reserved in the mixture. This problem requires a solution by alternative means, such as combining this kit with the CD3-positive selection kit, which can remove all CD3^+^ cells, including NKT cells and therefore improve the purity of NK cells. Furthermore, it was identified with DX5-positive selection that the NK cell purity of isolates was variable based on the different markers used. The Stemcell CD49b Positive Selection kit is a typical representation. Following isolation, the purity of CD49b-positive cells was \>95% in the isolated cells, whereas the purity of CD49b^+^CD3ε^−^ cells was \~80% and the purity of NK1.1^+^CD3ε^−^ cells was \~65%. The different purity of NK cells based on different markers was also associated with the expression of CD49b ([@b16-etm-0-0-4189],[@b17-etm-0-0-4189]). Therefore, when the purity of isolated NK cells was identified using the DX5-positive selection kit, the classic surface markers were revealed to be the preferential choice over other markers. Consequently, isolating NK cells using only the CD49b-positive strategy is not recommended; however, this kit provides improved results when combined with the CD3-positive selection kit.

Although combining the use of CD3ε positive selection with DX5 positive selection may improve the purity of NK cell, the time required for isolation was extended. Additionally, the NK cell is a functionally and phenotypically heterogeneous population ([@b18-etm-0-0-4189]) and perhaps only a specific subpopulation is isolated by positive selection. It has also been described that *in vitro* cultured NK cells are no longer recognized by DX5 antibodies ([@b19-etm-0-0-4189]). Moreover, DX5 is not expressed on immature NK cells and tissue-resident NK cells in the liver ([@b20-etm-0-0-4189],[@b21-etm-0-0-4189]). Therefore, the isolation of NK cells via CD49b as a positive selection marker should be undertaken depending on the experiment requirements. The negative selection of NK cells can capture naïve cells. It is critical that functional studies are performed in the future. There are several advantages of negative selection with one of these being that the NK cells are not coated with antibody and, therefore, are not at risk of functional perturbation by antibody cross-linking. Additionally, negative selection provides a way to isolate diverse subpopulations of NK cells without selectively purifying a specific subpopulation ([@b13-etm-0-0-4189]). In our comparative experiments, high purity and yield of NK cells were obtained in a shorter time frame using the negative selection method, particularly with the Stemcell Mouse NK Cell Isolation kit. The Miltenyi NK Cell Isolation kit II was also indicated to be a suitable choice of kit if the granulocytes of the spleen are depleted prior to sorting.

NK cells are short-lived and IL-2 dependent *in vitro* ([@b22-etm-0-0-4189]). IL-2 exposure; however, will result in differences owing to activation, such as NK cell killing of a broader panel of targets, which may be inappropriate for certain experimental settings. Therefore, a suitable concentration of IL-2 is critical for specific studies. In the present report, the NK cell purity and viability was compared with or without different concentrations of IL-2 (0, 100, 300 or 500 U/ml), following culturing for 24, 48 or 72 h using the Stemcell negative selection kit. Without IL-2, the purity of NK cells significantly decreased over time; however, with the addition of 100 U/ml IL-2, the NK cell purity may be maintained at \>80% after 72 h. The purity increased with increased concentrations of IL-2 at the same time point, and with the same concentration of IL-2 the purity was approximately the same at different time points. Consequently, the purity of NK cells was able to meet the requirement of the experiment no matter what concentration of IL-2 was used. However, the IL-2 concentration was critical for the viability of NK cells at different time points. Only 20% of NK cells were viable following 24 h without IL-2, and after 72 h \~10% were viable. Therefore, if studies wish to use NK cells *in vitro* for \>24 h, IL-2 is required. The viability of NK cells was increased with high concentrations of IL-2 at the same time point, particularly at 48 and 72 h. At a concentration of 100 or 300 U/ml of IL-2, the viability of NK cell was increased at 72 h when compared with 48 h exposure. Notably, the viability of NK cells was similar at different time points with 500 U/ml IL-2, which may be explained by NK cell proliferation. High concentrations (500 U/ml) of IL-2 are able to activate more NK cells to proliferate, which results in a balance between death and proliferation of NK cells. Thus, at different time points, the viability of NK cells is similar. However, low concentrations (100 or 300 U/ml) of IL-2 are not able to activate more NK cells to proliferate; therefore, if a study requires the use of NK cells *in vitro* for 24 h, the concentration of 300 U/ml IL-2 is recommended, based on the present results. If a study requires the use of NK cells *in vitro* for 48 or 72 h, a concentration of 500 U/ml IL-2 is recommended.

In conclusion, it is important to consider that different NK cell isolation kits affect the purity and yield of isolated NK cells. When isolating NK cells using Miltenyi kits, the spleen cells should be pretreated to deplete the granulocytes prior to sorting. Combined use of the CD3ε selection kit with the DX5 selection kit is able to produce higher purity and yield of NK cells. We favor the use of the negative selection kit from Stemcell, which can produce naïve NK cells that may be further analyzed. The present study revealed that IL-2 is essential for the viability of NK cells *in vitro*. The present study concludes that a concentration of 300 U/ml of IL-2 is recommended for the culture NK cells *in vitro* for 24 h to obtain optimal resolution and 500 U/ml of IL-2 is suitable for NK cells *in vitro* for 48 or 72 h.
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![FCM analysis of purified splenic NK cells using a Miltenyi CD49b (DX5) positive selection kit. Purity of NK cell isolates was evaluated using FCM. The indicated percentage of contaminated granulocytes was represented as the granulocytes population (P2)/total cell population ×100. NK cell purity is shown as a percentage of the total gated viable lymphocyte population. NK cells were defined as NK1.1^+^CD3ε^−^. The indicated percentages represent the purity efficacy represented as the NK cell population/total viable lymphocyte population (P1) ×100. The percentage of NKT cell defined as NK1.1^+^CD3ε^+^ was also indicated. This plot is one representative experiment obtained from at least three separate assays performed in parallel. FCM, flow cytometry; NK, natural killer; FSC, forward scatter; SSC, side scatter; FITC, fluorescein isothiocyanate; PE, phycoerythrin; NKT cell, natural killer T cell.](etm-13-05-1875-g00){#f1-etm-0-0-4189}

![FCM analysis of purified splenic NK cells using a Miltenyi NK cell isolation kit II. (A) Purity of NK cell isolates were evaluated using FCM. NK cell purity is shown as a percentage of the total gated viable lymphocyte population (P1). NK cells were defined as NK1.1^+^CD3ε^−^. The indicated percentages represent the purity efficacy represented as the NK cell population/total viable lymphocyte population (P1) ×100. A large population at the position of granulocytes (P3) was identified using F4/80 antibody. (B) Purity of NK cells and the contaminated granulocytes were evaluated using FCM following culturing with 500 U/ml of IL-2 for 24 h. This plot is one representative experiment obtained from at least three separate assays performed in parallel. FCM, flow cytometry; NK, natural killer; CD, cluster of differentiation; FSC, forward scatter; SSC, side scatter; FITC, fluorescein isothiocyanate; PE, phycoerythrin.](etm-13-05-1875-g01){#f2-etm-0-0-4189}

![FCM analysis of purified splenic NK cells using a Stemcell CD49b positive selection kit. NK cell purity is shown as a percentage of the total gated viable lymphocyte population (P1). The histogram represents the percentage of CD49b^+^ cells of P1. NK cells were defined as NK1.1^+^CD3ε^−^ or CD49b^+^CD3ε^−^. The indicated percentages represent the purity efficacy represented as the NK cell population/total viable lymphocyte population (P1) ×100. The percentage of NKT cell, defined as NK1.1^+^CD3ε^+^, was also indicated. This plot is one representative experiment obtained from at least three separate assays performed in parallel. FCM, flow cytometry; NK, natural killer; CD, cluster of differentiation; FSC, forward scatter; SSC, side scatter; FITC, fluorescein isothiocyanate; PE, phycoerythrin; NKT cell, natural killer T cell.](etm-13-05-1875-g02){#f3-etm-0-0-4189}

![FCM analysis of purified splenic NK cells using a Stemcell mouse NK cell isolation kit. NK cell purity is shown as a percentage of the total gated viable lymphocyte population (P1). The indicated percentage represents the purity efficacy represented as the NK cell population/total viable lymphocyte population (P1) ×100. This plot is one representative experiment obtained from at least three separate assays performed in parallel. FCM, flow cytometry; NK, natural killer; FSC, forward scatter; SSC, side scatter; FITC, fluorescein isothiocyanate; PE, phycoerythrin.](etm-13-05-1875-g03){#f4-etm-0-0-4189}

![FCM analysis of purified splenic NK cells using a modified NK cell isolation protocol. (A) Results from using the Miltenyi CD3ε MicroBead kit. CD4^+^ and CD8^+^ cell purity is shown as a percentage of the total gated viable lymphocyte population (P1). The indicated histogram percentages represent the purity efficacy represented as the CD4^+^ or CD8^+^ cell population/total viable lymphocyte population (P1) ×100. (B) Results of using the Miltenyi CD3ε MicroBead kit in combination with the Miltenyi CD49b (DX5) positive selection kit. The indicated percentage of contaminated granulocytes represented as the granulocytes population (P2)/total cell population ×100. NK cell purity is shown as a percentage of the total gated viable lymphocyte population (P1). The indicated histogram percentages represent the NK1.1^+^ cell population/total viable lymphocyte population (P1) ×100. FCM, flow cytometry; NK, natural killer; CD, cluster of differentiation; FSC, forward scatter; SSC, side scatter; FITC, fluorescein isothiocyanate; PE, phycoerythrin.](etm-13-05-1875-g04){#f5-etm-0-0-4189}

![Analysis of the purity and viability of NK cells in the presence of different concentrations of IL-2 by FCM. Purity and viability of NK cell were evaluated using FCM following culturing for (A) 24, (B) 48 or (C) 72 h. All cells, except debris, were gated based on FSC and SSC. Subsequently, 7-AAD was used to identify the percentage of viable cells. NK cell purity was assessed in viable cells using NK1.1^+^CD3ε^−^. (D) Viability and (E) purity of NK cells following culturing for 24, 48, and 72 h. Data are expressed as mean ± standard deviation. \*P\<0.05 vs. the group treated with 0 U/ml of IL-2; ^\#^P\<0.05 vs. the group treated with 100 U/ml of IL-2; ^Δ^P\<0.05 vs. the group treated with 300 U/ml of IL-2. FCM, flow cytometry; NK, natural killer; 7-AAD, 7-aminoactinomycin D; IL-2, interleukin-2; FSC, forward scatter; SSC, side scatter; FITC, fluorescein isothiocyanate; PE, phycoerythrin.](etm-13-05-1875-g05){#f6-etm-0-0-4189}

![NK cell purity and the time required for isolation in different kits. The left Y-axis represents the NK cell purity obtained using the different methods. Data are expressed as mean ± standard deviation. The right Y-axis represents the time required for purification, according to manufacturer\'s instructions of each respective kit. \*P\<0.05. NK, natural killer; CD, cluster of differentiation.](etm-13-05-1875-g06){#f7-etm-0-0-4189}

###### 

Purity and viability of NK cells with different concentration of IL-2.

        NK cells purity of living cell, %                                                                       Viable cell/total cell, %                                                                                                                                                                                                                                                                                                                                                                                                        
  ----- ------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------
    0   72.57±4.30                                                                                              53.37±5.44                                                                                              22.13±3.67                                                                                              21.10±4.78                                                                                              9.23±1.93                                                                                                7.50±1.05
  100   83.70±5.16^[a](#tfn2-etm-0-0-4189){ref-type="table-fn"}^                                                81.83±3.95^[a](#tfn2-etm-0-0-4189){ref-type="table-fn"}^                                                82.17±3.50^[a](#tfn2-etm-0-0-4189){ref-type="table-fn"}^                                                45.77±5.34^[a](#tfn2-etm-0-0-4189){ref-type="table-fn"}^                                                29.13±3.39^[a](#tfn2-etm-0-0-4189){ref-type="table-fn"}^                                                 32.17±3.15^[a](#tfn2-etm-0-0-4189){ref-type="table-fn"}^
  300   94.07±2.51^[a](#tfn2-etm-0-0-4189){ref-type="table-fn"},[b](#tfn3-etm-0-0-4189){ref-type="table-fn"}^   90.83±3.03^[a](#tfn2-etm-0-0-4189){ref-type="table-fn"},[b](#tfn3-etm-0-0-4189){ref-type="table-fn"}^   92.73±2.30^[a](#tfn2-etm-0-0-4189){ref-type="table-fn"},[b](#tfn3-etm-0-0-4189){ref-type="table-fn"}^   71.30±3.29^[a](#tfn2-etm-0-0-4189){ref-type="table-fn"},[b](#tfn3-etm-0-0-4189){ref-type="table-fn"}^   43.50±3.24^[a](#tfn2-etm-0-0-4189){ref-type="table-fn"},[b](#tfn3-etm-0-0-4189){ref-type="table-fn"}^    52.23±3.70^[a](#tfn2-etm-0-0-4189){ref-type="table-fn"},[b](#tfn3-etm-0-0-4189){ref-type="table-fn"}^
  500   95.20±1.49^[a](#tfn2-etm-0-0-4189){ref-type="table-fn"},[b](#tfn3-etm-0-0-4189){ref-type="table-fn"}^   95.97±1.55^[a](#tfn2-etm-0-0-4189){ref-type="table-fn"},[b](#tfn3-etm-0-0-4189){ref-type="table-fn"}^   95.63±1.14^[a](#tfn2-etm-0-0-4189){ref-type="table-fn"},[b](#tfn3-etm-0-0-4189){ref-type="table-fn"}^   74.60±2.02^[a](#tfn2-etm-0-0-4189){ref-type="table-fn"},[b](#tfn3-etm-0-0-4189){ref-type="table-fn"}^   71.90±1.25^[a](#tfn2-etm-0-0-4189){ref-type="table-fn"}--[c](#tfn4-etm-0-0-4189){ref-type="table-fn"}^   72.30±2.10^[a](#tfn2-etm-0-0-4189){ref-type="table-fn"}--[c](#tfn4-etm-0-0-4189){ref-type="table-fn"}^

Values are expressed as mean ± standard deviation. NK, natural killer; IL-2, interleukin-2

P\<0.05 vs. the group treated with 0 U/ml of IL-2

P\<0.05 vs. the group treated with 100 U/ml of IL-2

P\<0.05 vs. the group treated with 300 U/ml of IL-2.
